Item

VIT B5 D-CAL PAN BROTHER 25KG (1100341)

D-calcium pantothenate
Nutrient / Vitamin
Attributes
  • Gluten-free
  • Halal
  • Ingredient declaration
  • Kosher
  • PHO-free
  • Ready-to-Eat (RTE)
  • Vegan
  • Non-GMO
Locations
Location name Address
Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical Jishan Industrial Park Pengze Town Jiujiang CIty, Jiangxi Provence 332700 CHN
Documents
Type Location File name Effective Expiration
Shelf Life Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical 1100341 - CA2012065 3.pdf 6/4/2021 6/3/2024
EtO Statement Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical 1100341 Vit B5 D-Cal Pan - ETO Statement.pdf 8/19/2023 8/18/2025
GRAS/NDI/ODI Statement Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical 1100341 Vit B5 D-Cal Pan - GRAS Statement.pdf 8/15/2023 8/14/2026
Pesticide Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical 1100341 Vit B5 D-Cal Pan - Pesticides Statement (2).pdf 8/19/2023 8/18/2025
Safety Data Sheet (SDS) Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical 1100341 Vit B5 D-Cal Pan - Safety Data Sheet.pdf 10/25/2022 10/24/2024
Product Specification Sheet Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical 1100341 Vit B5 D-Cal Pan - Specification Technical Data Sheets.pdf 5/7/2021 5/6/2024
BSE - TSE Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical 1100341 Vit B5 D-Cal Pan - TSE&BSE Free Statement.pdf 7/28/2023 7/27/2026
Allergens Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical Allergens.pdf 12/18/2023 12/17/2025
California Prop. 65 Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical California Proposition 65 Statement.pdf 7/17/2022 7/16/2024
Country of Origin Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical Country of Origin.pdf 10/5/2021 10/4/2024
Irradiation Status Statement Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical Irradiation - ETO- Statement.pdf 7/17/2022 7/16/2024
Suitability Requirements Glanbia Nutritionals Inc. - Jiangxi Brother Pharmaceutical Suitability Requirements.pdf 10/5/2021 10/4/2024